AI assistant
INDUSTRIALS REIT LIMITED Director's Dealing 2021
5162_dirs_2021-01-07_c0580914-1908-44cc-bf08-87cfdec4c0d1.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 8325K
Stenprop Limited
07 January 2021
STENPROP LIMITED
(Registered in Guernsey)
(Registration number 64865)
LSE share code: STP JSE share code: STP
ISIN: GG00BFWMR296
("Stenprop" or the "Company")
DEALING BY A PERSON DISCHARGING MANAGERIAL RESPONSIBILITY
7 January 2021
Shareholders are advised of the following information relating to the sale of the Company's securities by a person discharging managerial responsibility:
| Name: | Neil Marais |
| Position: | Director of Stenprop (Swiss) Limited and Stenprop Trafalgar Limited, being subsidiaries of Stenprop |
| Transaction date: | 5 January 2020 |
| Class of securities: | Ordinary shares |
| Number of securities: | 12,608 |
| Price per security | GBP 1.3975 |
| Deemed total value of the transaction: | GBP 17,619.68 |
| Nature of transaction: Nature and extent of director's interest: Clearance to deal received: |
On-market sale on the London Stock Exchange Direct beneficial Yes |
For further information:
Stenprop Limited +44(0)20 3918 6600
Paul Arenson ([email protected])
Julian Carey ([email protected])
James Beaumont ([email protected])
Numis Securities Limited (Financial Adviser) +44(0)20 7260 1000
Hugh Jonathan
Vicki Paine
Justin Bell
FTI Consulting +44(0)20 3727 1000
Richard Sunderland [email protected]
Richard Gotla
Indraneel Bose
Java Capital +27 (0)11 722 3050
(JSE sponsor)
About Stenprop:
Stenprop is a UK REIT listed on the LSE and the JSE. The objective of the Company is to deliver sustainable growing income to its investors. Stenprop's investment policy is to invest in a diversified portfolio of UK multi-let industrial (MLI) properties with the strategic goal of becoming the leading MLI business in the UK. For further information, go to stenprop.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDKABQABKDADK